Please note that this event date is based off of the date of publication of the article as the event dates were not provided in the published literature.It was not possible to ascertain specific device information from the article or to match the events reported with previously reported events.Correspondence has been sent to the author of the article inquiring about individual patient information and additional information regarding the reported events.Concomitant medical products: product id 3387, lot# unknown, product type: lead.(b)(4).
|
Luyten, l., hendrickx, s., raymaekers, s., gabriels, l., nuttin, b.Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder.Molecular psychiatry.2015.1-9.Doi: 10.1038/mp.2015.124.Summary: in 1998, we proposed deep brain stimulation as a last-resort treatment option for patients suffering from severe, treatment-resistant obsessive-compulsive disorder (ocd).Here, 24 ocd patients were included in a long-term follow-up study to evaluate the effects of electrical stimulation in the anterior limbs of the internal capsule (alic) and bed nucleus of the stria terminalis (bst).We find that electrical stimulation in the alic/bst area is safe and significantly decreases obsessions, compulsions, and associated anxiety and depressive symptoms, and improves global functioning in a blinded crossover trial (n = 17), after 4 years (n = 18), and at last followup (up to 171 months, n = 24).Moreover, our data indicate that bst may be a better stimulation target compared with alic to alleviate ocd symptoms.We conclude that electrical stimulation in bst is a promising therapeutic option for otherwise treatment resistant ocd patients.Reported events: patient 18: one (b)(6) female patient with bilateral deep brain stimulation (dbs) targeting the bed nucleus of the stria terminalis (bst) to treat obsessive compulsive disorder (ocd) experienced absences or partial epileptic seizures 57 months after device implant.This was considered "probably stimulation induced." in addition, it was noted that the patient displayed no quantifiable neurological or cardiovascular abnormalities, as assessed with interictal electroencephalogram and holter monitoring.The author stated that of the two female patients with absence or partial epileptic seizures, one of them only experience absences during stimulation.Another patient continued to have seizures after turning off stimulation.The third patient only developed symptoms after one electrode was replaced and implanted in a slightly posterior target.It is unknown which conditions led to seizures in this patient as the author did not clarify which situation applied to this patient.Further information has been requested; a supplemental report will be submitted if additional information is received.
|